Earlier in the week, ARK purchased 10,353 shares of CRISPR on Wednesday, valued at $584,530, and 43,333 shares on Tuesday, totaling $2,509,414. This consistent buying pattern suggests a strong ...

As per its latest quarterly results, CRISPR posted a whopping $1.9 billion in its cash till, offering it sufficient room to ...

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made just one trade on Friday, December 26, according to its daily fund disclosures. The ...

Congress Wealth Management LLC DE purchased a new stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional ...

HC Wainwright reiterated their buy rating on shares of CRISPR Therapeutics (NASDAQ:CRSP – Free Report) in a research report released on Tuesday,Benzinga reports. HC Wainwright currently has a $80.00 ...

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough. You can follow him investing $500,000 of his own money on our top AI stocks for free.

Each week we publish a summary of a few of the articles, topics and ideas found in the MoSI chat. We encourage you to visit chat to read about updates to our investments, share ideas, and ask ...